NEW YORK, Dec. 1, 2011 /PRNewswire/ -- TheraBiogen, Inc. (OTC BB: TRAB), a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches, today announced its partnership with Megale Public Relations to promote TheraMax Cold & Flu.
“TheraMax is a quantum leap in cold and flu relief and we couldn’t be more excited to be a part of this project,” commented Megan Megale, President of Megale Public Relations. She continued, “As was the case in years prior, with the potential shortage of flu vaccines and those that wish not to be inoculated, TheraMax offers an effective alternative in treating the symptoms of the flu in the estimated $2.5 billion dollar market.”
Megale Public Relations will implement a global strategy, inclusive of media relations, product integration, co-branding opportunities and celebrity seeding complemented with an integrated advertising campaign. In order to read Megale Public Relations’ news regarding TheraBiogen and for additional information about the company, please visit www.megalepr.com.
Kelly Hickel, CEO of TheraBiogen, commented, “We are pleased to have Megale Public Relations on our team. As we have communicated, we are determined to do all we can to bring consumer awareness to our unique and all natural, non-zinc alternative to cold and flu suffers this flu season.”
TheraMax is available for purchase in over twelve thousand locations including Rite-Aid, Food Lion, Hannaford Supermarkets, Discount Drug Marts, Big Y Supermarkets and others. For more information on TheraMax visit our website at www.theramaxrelief.com, our Facebook page at facebook.com/theramaxnasalspray or follow us on Twitter at http://twitter.com/TheraMaxRelief.
About Megale Public Relations:
Megale Public Relations is a public relations agency with media expertise combined with a fierce sense of business development. It is fully equipped to address all PR needs and has the innate ability to ensure the strategy implemented is one that will not only achieve its clients goals from a media perspective, but will also enhance the financial success of the campaign, product or brand. For more information please visit the company web site at www.megalepr.com.
About TheraBiogen, Inc.
TheraBiogen, Inc. is a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches. The products are made from natural, homeopathic ingredients and contain no zinc, which has been identified as potentially causing nasal problems in other similar products on the market. For further information please visit www.theramaxrelief.com.
Safe Harbor Statement
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risk that could cause actual performance and results of operations to differ materially from those anticipated. These risks are set forth in the Company’s most recently filed form 10-K and Form 10-Q reports. TheraBiogen, Inc. assumes no obligation to update the statements contained in this release except as required by applicable securities laws disclosure rules.
Company Contact: | Public Relations Contact: | Investor Contact: |
TheraBiogen, Inc. | Megan Megale | Boutcher & Boutcher |
Kelly T. Hickel, CEO | Megale Public Relations | Aimee Boutcher |
646-808-3095 | 703-625-8093 | 973-239-2878 |
mmegale@megalepr.com |
|
SOURCE TheraBiogen, Inc.
